Take Aspirin To Prevent Cancer - Bare Skin Care

by Charles Bollmann October 31, 2015

Dr Bollmann, Skin Care Specialist, Anti-Aging Expert

Many doctors have been recommending low-dose Aspirin to prevent heart disease and stroke for some time. I personally take one every morning. Usually the dose ranges from 75 to 81 mg, and are readily available at low cost in pharmacies and food stores. It is wise to check with your doctor before initiating this, however.

Now other benefits from this regimen are being reported, including cancer prevention, mostly colorectal cancer.

Below is from the magazine - "Cancer"

"A number of previous studies suggest that aspirin and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen may help protect against colorectal cancer.  Soren Friis, from the Danish Cancer Society Research Center (Denmark), and colleagues analyzed data collected on over 113,000 Danish men and women, a subset of which had first-time colorectal cancer.  The team found that the subjects who took low-dose aspirin continuously for at least five years were at 27% reduced risk of colorectal cancer; and those using nonaspirin NSAIDs for at least five years were at 30% reduced risk. The study authors write that: “Long-term, continuous use of low-dose aspirin and long-term use of nonaspirin NSAIDs were associated with reduced colorectal cancer risk.”

To me, the benefit/risk ratio is preponderantly on the benefit side.

Charles Bollmann
Charles Bollmann

Leave a comment

Comments will be approved before showing up.

Also in Dr Bollmann's Blog


by Charles Bollmann May 17, 2020

Read More
A Doctor's Thoughts On Coronavirus - Bare Skin Care

by Charles Bollmann April 24, 2020

But I am confident that when statistics of this pandemic have been reviewed, we will find out the INCREASED STRESS from shutting the country down and social isolation will have caused more deaths from suicides, alcohol/drug abuse, domestic abuse, and financial disasters than the Coronavirus.
Read More
Corona Virus Strain? A Little Levity

by Charles Bollmann April 20, 2020

Read More